School of Medicine: Established in 1930, Duke University School of Medicine is the youngest of the nation's top medical schools. Ranked sixth among medical schools in the nation, the School takes pride in being an inclusive community of outstanding learners, investigators, clinicians, and staff where interdisciplinary collaboration is embraced and great ideas accelerate translation of fundamental scientific discoveries to improve human health locally and around the globe. Composed of more than 2,600 faculty physicians and researchers, nearly 2,000 students, and more than 6,200 staff, the Duke University School of Medicine along with the Duke University School of Nursing, and Duke University Health System comprise Duke Health, a world-class academic medical center. The Health System encompasses Duke University Hospital, Duke Regional Hospital, Duke Raleigh Hospital, Duke Health Integrated Practice, Duke Primary Care, Duke Home Care and Hospice, Duke Health and Wellness, and multiple affiliations. Be You. The laboratory of Dr. Akinyemiju leads impactful programs to advance health equity across the research, training and service missions. This includes strengthening partnerships and building trust with diverse communities, fostering multi-directional stakeholder engagement strategies to enhance impact, and training the next generation of talented, diverse trainees in cancer research and population health. She leads efforts to generate empirical and actionable insights that target specific drivers of health disparities within our institution and nationwide, to eliminate health disparities and advance cancer health equity. Dr. Akinyemiju is currently the PI of three ongoing studies on cancer disparities: 1 a study of West African Nigeria and The Gambia, African-American and White breast cancer cases characterizing the role of ancestry-related factors, metabolic dysregulation and genomic alterations to identify reasons why women of West African descent have the highest global triple negative breast cancer rates; 2 a prospective cohort study of 1,600 Black, Hispanic and White ovarian cancer patients in the US characterizing mechanisms by which healthcare access and microbiome profiles influence treatment quality, supportive care and survival; and 3 a prospective cohort study evaluating the mechanisms through which systemic racism structural, cultural and interpersonal racism impacts US breast cancer disparities. This position is: Onsite. The work is performed on-site or at a designated assignment location. Be Bold. Key Responsibilities: Perform duties related to sponsored research project. Choose Duke Be part of a dynamic team committed to innovating in the fields of genomics, nutrition, and public health. Our lab offers a stimulating environment where your contributions will have a meaningful impact on scientific research and public health. We welcome applicants who are passionate about advancing genomic technologies and are ready to embark on a
